SECsense Logo

PainReform Ltd. Reports $3.17M Capital Influx in SEC Form 6-K Filing

$PRFX
Form 6-K
Filed on: 2025-01-02
Source
PainReform Ltd. Reports $3.17M Capital Influx in SEC Form 6-K Filing

Here are the key insights extracted from the provided section of the financial report:

  1. Document Type and Filing Details:
  • The document is a Form 6-K, which is used by foreign private issuers to report certain material events.
  • It is filed with the SEC (Securities and Exchange Commission) and is dated January 2, 2025.
  1. Company Information:
  • The report is filed by PainReform Ltd., which is located at 65 Yigal Alon St., Tel Aviv, Israel.
  • The Commission File Number associated with the company is 001-39481.
  1. Compliance with SEC Regulations:
  • The report will be incorporated by reference into the company's Registration Statements on Form S-8 and Form F-3.
  1. Warrants Exercise:
  • In December 2024, 494,650 warrants to purchase ordinary shares were exercised.
  • This transaction generated approximately $3.17 million in gross proceeds for the company.
  1. Signatory Information:
  • The report is signed by Ehud Geller, who is the Executive Chairman of the Board and Interim Chief Executive Officer of PainReform Ltd.
  1. Annual Report Filing:
  • The company indicates that it does not file annual reports under Form 20-F but may file under Form 40-F.

Overall, the report highlights a significant financial development for PainReform Ltd. regarding the exercise of warrants, leading to substantial capital influx, and provides essential regulatory compliance information.